|
XL147
|
XL147
|
956958-53-5
|
|
GSK-3787
|
GSK-3787
|
188591-46-0
|
|
ETP-46321
|
CS-2500
|
1252594-99-2
|
|
EPZ015666
|
EPZ015666
|
1616391-65-1
|
|
Lasmiditan hemisuccinate
|
琥珀酸拉斯米迪坦
|
439239-92-6
|
|
Lasmiditan hydrochloride
|
613677-28-4
|
613677-28-4
|
|
Afatinib
|
阿法替尼
|
439081-18-2
|
|
Brivanib alaninate
|
1-[[4-[(4-氟-2-甲基-1H-吲哚-5-基)氧基]-5-甲基吡咯并[2,1-F][1,2,4]三嗪-6-基]氧基]-2-丙醇 L-丙氨酸酯
|
649735-63-7
|
|
Cediranib maleate
|
西地尼布馬來酸鹽
|
857036-77-2
|
|
Lu AE58054 HCl salt
|
N-[2-(6-氟-1H-吲哚-3-基)乙基]-3-(2,2,3,3-四氟丙氧基)芐基胺單鹽酸鹽
|
467458-02-2
|
|
LY-900009
|
LY900009
|
209984-68-9
|
|
AZ5104
|
奧西替尼中間體
|
1421373-98-9
|
|
SU 5205
|
SU 5205; SU-5205; SU5205
|
3476-86-6
|
|
Lusutrombopag
|
蘆曲泊帕
|
1110766-97-6
|
|
Methyl 2,5-dihydroxycinnamate
|
2,5-二羥基肉桂酸甲酯
|
63177-57-1
|
|
Obatoclax mesylate
|
Obatoclax 甲磺酸鹽
|
803712-79-0
|
|
Mubritinib
|
木利替尼
|
366017-09-6
|
|
Rostafuroxin
|
ROSTAFUROXIN
|
156722-18-8
|
|
Tertiapin
|
tertiapin
|
58694-52-3
|
|
Lavendustin A
|
薰草菌素
|
125697-92-9
|
|
Vatalanib
|
瓦他拉尼堿
|
212141-54-3
|
|
AZD-8931
|
AZD8931
|
848942-61-0
|
|
HMN-214
|
(E)-4-[2-[2-[N-乙?；?N-[(4-甲氧基苯基)磺酰]氨基]苯基]乙烯基]吡啶 1-氧化物
|
173529-46-9
|
|
UNC-0638
|
UNC0638
|
1255580-76-7
|
|
Icotinib hydrochloride
|
凱美納
|
1204313-51-8
|
|
AZD9291DA
|
AZD9291中間體1
|
1421372-66-8
|
|
Fruquintinib
|
呋喹替尼
|
1194506-26-7
|
|
E7046
|
E-7046
|
1369489-71-3
|
|
Almotriptan Malate
|
依來曲普坦
|
181183-52-8
|
|
DSP-6952 hydrobromide
|
Minesapride
|
1184661-33-3
|
|
Asenapine maleate
|
阿塞那平馬來酸鹽
|
85650-56-2
|
|
Zibotentan
|
齊泊騰坦
|
186497-07-4
|
|
Eltoprazine hydrochloride
|
1-(2,3-二氫苯并[B][1,4]二氧雜芑-5-基)哌嗪
|
98206-09-8
|
|
SU5408
|
VEGFR2 KISE INHIBITOR I
|
15966-93-5
|
|
Quinine hemisulfate dihydrate
|
硫酸奎寧
|
6119-70-6
|
|
Irbinitinib
|
妥卡替尼
|
937263-43-9
|
|
IOX2
|
IOX 2
|
931398-72-0
|
|
17-Phenyl Trinor Prostaglandin F2α Methyl Amide
|
比馬前列素甲胺
|
155206-01-2
|
|
AZD8186
|
8-[(1R)-1-[(3,5-二氟苯基)氨基]乙基]-N,N-二甲基-2-(4-嗎啉基)-4-氧代-4H-1-苯并吡喃-6-甲酰胺
|
1627494-13-6
|
|
AG-1557
|
AG-1557
|
189290-58-2
|
|
JK-P3
|
3,4-二甲氧基-N-(5-苯基-1H-吡唑-3-基)苯甲酰胺
|
942655-44-9
|
|
EGF816
|
EGF816
|
1508250-71-2
|
|
EPZ015866
|
GSK591 (EPZ-015866)
|
1616391-87-7
|
|
Lanifibranor
|
IVA-337
|
927961-18-0
|
|
PD123319
|
PD 123319
|
130663-39-7
|
|
Cediranib dihydrochloride
|
西地尼布
|
288383-20-0
|
|
GDC0941
|
GDC-0941
|
957054-30-7
|
|
Darusentan
|
達盧生坦
|
171714-84-4
|
|
Palosuran
|
ACT 058362; PALOSURAN,
|
540769-28-6
|
|
CPI-444
|
CPI-444
|
1202402-40-1
|
|
Elafibranor
|
GFT505
|
923978-27-2
|
|
SU 4942
|
SU 4942; SU-4942; SU4942
|
76086-99-2
|
|
hVEGF-IN-1
|
1637443-98-1
|
1637443-98-1
|
|
KNK437
|
KNK437
|
218924-25-5
|
|
AV-412
|
AV-412
|
451492-95-8
|
|
WZ-4002
|
WZ4002
|
1213269-23-8
|
|
Rigosertib sodium
|
N-[2-甲氧基-5-[[[2-(2,4,6-三甲氧基苯基)乙烯基]磺酰]甲基]苯基]甘氨酸鈉鹽
|
1225497-78-8
|
|
GW 627368X
|
GW627368X
|
439288-66-1
|
|
Copanlisib
|
庫潘尼西
|
1032568-63-0
|
|
Regorafenib Hydrochloride
|
瑞格非尼鹽酸鹽
|
835621-07-3
|
|
Regorafenib monohydrate
|
瑞格非尼一水合物
|
1019206-88-2
|
|
Naquotinib
|
NAQUOTINIB
|
1448232-80-1
|
|
CID5721353
|
301356-95-6
|
301356-95-6
|
|
AG 1406
|
AG1406;AG-1406
|
71308-34-4
|
|
AVN-492
|
CS-2812
|
1220646-23-0
|
|
GW3965 Hydrochloride
|
2-[3-[3-[[2-氯-3-(三氟甲基)芐基](2,2-二苯基乙基)氨基]丙氧基]苯基]乙酸鹽酸鹽
|
405911-17-3
|
|
AS-604850
|
5-[(2,2-二氟-1,3-苯并二惡茂-5-基)亞甲基]噻唑烷-2,4-二酮
|
648449-76-7
|
|
Oglufanide
|
H-GLU-TRP-OH
|
38101-59-6
|
|
GlyH-101
|
GLYH 101
|
328541-79-3
|
|
GSK-461364
|
GSK461364
|
929095-18-1
|
|
Umbralisib
|
TGR-1202
|
1532533-67-7
|
|
3-Methyltoxoflavin
|
3-methyl toxoflavin
|
32502-62-8
|
|
MS023
|
N1-甲基-N1-[[4-[4-(異丙氧基)苯基]-1H-吡咯-3-基]甲基]-1,2-乙二胺
|
1831110-54-3
|
|
MSDC-0602
|
1133819-87-0
|
1133819-87-0
|
|
Vortioxetine HBr
|
氫溴酸沃替西汀
|
960203-27-4
|
|
XL 765
|
XL765
|
1349796-36-6
|
|
UNC1215
|
UNC1215
|
1415800-43-9
|
|
Pilaralisib
|
2-氨基-N-[3-[N-[3-[(2-氯-5-甲氧基苯基)氨基]喹喔啉-2-基]氨基磺?；鵠苯基]-2-甲基丙酰胺
|
934526-89-3
|
|
Mutant EGFR inhibitor
|
N-[5-[[5-氯-4-(1H-吲哚-3-基)-2-嘧啶基]氨基]-2-[[2-(二甲基氨基)乙基]甲基氨基]-4-甲氧基苯基]-2-丙烯酰胺
|
1421373-62-7
|
|
GS967
|
GS967
|
1262618-39-2
|
|
MDK34597
|
PIK抑制劑
|
371934-59-7
|
|
Vabicaserin hydrochloride
|
VABICASERIN HYDROCHLORIDE
|
887258-94-8
|
|
Cloprostenol sodium
|
氯前列烯醇鈉
|
55028-72-3
|
|
Tivozanib
|
替沃扎尼
|
475108-18-0
|
|
AC-55541
|
AC-55541
|
916170-19-9
|
|
Preladenant
|
瑞德南特
|
377727-87-2
|
|
Icotinib
|
?？颂婺?/a>
|
610798-31-7
|
|
EAI045
|
EAI-045
|
1942114-09-1
|
|
BMS-779788
|
化合物XL652
|
918348-67-1
|
|
WAY-100635 maleate
|
WAY-100635
|
634908-75-1
|
|
Naronapride dihydrochloride
|
CS-632
|
860169-57-9
|
|
Semaxanib
|
SU5416
|
204005-46-9
|
|
SB-3CT
|
SB-3CT
|
292605-14-2
|
|
Brivanib
|
布立尼布
|
649735-46-6
|
|
SB742457
|
3-苯基磺?；?8-(哌嗪-1-基)喹啉
|
607742-69-8
|
|
PIK 75 hydrochloride
|
2-甲基-5-硝基苯磺酸 [(6-溴咪唑并[1,2-A]吡啶-3-基)亞甲基]甲基肼鹽酸鹽
|
372196-77-5
|
|
CL-387785
|
CL-387785
|
194423-06-8
|
|
CNX-2006
|
CNX2006
|
1375465-09-0
|
|
VPS34-IN1
|
VPS34-IN1
|
1383716-33-3
|
|
3-Methyladenine
|
6-氨基-3-甲基嘌呤
|
5142-23-4
|